In the past, native computed tomography of the neurocranium (CCT) was often the only procedure to diagnose a stroke. Technical limitations of previous generations of scanners made their use impractical for complementary methods of visualising blood vessels or for perfusion imaging. With the introduction of multi-slice spiral CT these technical limitations disappeared and both perfusion CT (PCT)…
Diagnostic imaging is of particular value in investigating ischaemic cerebrovascular accidents since, due to the rapid progression of cell destruction in the region of the cerebral infarction, the radiologist is faced with urgent questions regarding a possible procedure. These questions may be answered particularly well using computed tomography (CT). The following article provides an overview…
A joint project of more than 30 European stroke units just started to examine a potential connection between Fabry disease and stroke in young patients. The results of the worldwide SIFAP (Stroke in Young Fabry Patients) study might give an explanation for some of the 25% of strokes with unknown origin in patients aged 18-55 years.
If something doesn't fit we make it fit, and if it doesn't exist we invent it: Pragmatism combined with imagination and idealism are the foundation stones of groundbreaking inventions that improve daily life in medicine.
The debate between carotid artery stenting (CAS) and carotid endarterectomy (CEA) - the surgical approach - for treating a narrowing of the carotid artery in the neck to prevent stroke has tipped in favour of the more proven procedure of operation.
Earlier disease detection will save healthcare services
The UK spends more of its healthcare budget on cardiovascular disease than any other country in the EU.
Stroke risk should determine anti-clotting treatment for people with irregular heartbeat.
´CT has been revolutionizing the understanding and treatment of stroke´ - that is the summary of Dr. Dzialowski.
Vascular experts urge caution over stent lacement to prevent stroke.
A connection has been discovered between raised levels of the liver enzyme Gamma-Glutamyl-Transferase (GGT) and the probability of death from diseases of the cardiovascular system or strokes.
Alfred E Schiller, founder and managing director of Schiller AG, based in Baar, Switzerland, describes the rise of his company and its place in today’s highly competitive intensive care market. Alfred Schiller founded Schiller AG in 1971 and three years later introduced his first product – a pocket-sized electrocardioscope, which has been built on successively over the years. The…
Spain - New research suggests that sleep apnoea is a new risk factor for death from stroke.
Blood pressure (BP) screening, either alone or in combination with other cardiovascular risk factors such as cholesterol levels, does not determine a person's chance of having a heart attack or stroke, reports Professor Malcolm Law and colleagues at the Wolfson Institute of Preventive Medicine in the Journal of Medical Screening.
A newly invented 'Polypill', composed of currently available drugs, may act as a 'vaccine' against heart disease, according to new research published in the British Medical Journal (28 June. BMJ 2003;326:1419).
Strokes are among the most common cause of death worldwide and one of the most common causes of disability. Mortality rates are decreasing due to improving care. Nevertheless, experts expect the absolute number of cases to rise in view of the ageing population. Read more about current research and treatment options here.
Neural networks are emblematic of complex systems, so it's no surprise that the field of neurology is eclectic and intricate, too. Main challenges for neurologists are therapies of and research on stroke, seizures, movement disorders such as Parkinson's disease, autoimmune disorders such as multiple sclerosis and dementias such as Alzheimer's disease.
